Header Logo

Connection

STEPHEN PATRICK to Pregnancy

Back to Details
This is a "connection" page, showing publications STEPHEN PATRICK has written about Pregnancy.
STEPHEN PATRICK
Connection Strength
3.260
Pregnancy
  1. A taxonomy of states' approaches to plans of safe care. Child Abuse Negl. 2026 Aug; 178:108169.
    View in: PubMed
    Score: 0.098
  2. A Policy Scan on Plans of Safe Care for Infants With Prenatal Substance Exposure. Hosp Pediatr. 2025 Dec 01; 15(12):1039-1047.
    View in: PubMed
    Score: 0.094
  3. Cost-Effectiveness of Treatment for Opioid Use Disorder in Pregnancy and Its Impact on Birth Outcomes. JAMA Pediatr. 2025 Nov 01; 179(11):1203-1216.
    View in: PubMed
    Score: 0.094
  4. Buprenorphine Treatment in Pregnancy and Maternal-Infant Outcomes. JAMA Health Forum. 2025 04 27; 6(4.11):e251814.
    View in: PubMed
    Score: 0.091
  5. Adapting a Risk Prediction Tool for Neonatal Opioid Withdrawal Syndrome. Pediatrics. 2025 Apr 01; 155(4).
    View in: PubMed
    Score: 0.090
  6. "Just Google It": A Qualitative Study of Reproductive-Age Women's Stigmatizing Experiences When Accessing Buprenorphine for Opioid Use Disorder. Womens Health Issues. 2025 Jan-Feb; 35(1):45-53.
    View in: PubMed
    Score: 0.088
  7. Sex and Gender Variables in Data Set Creation and Data Cleaning for Inclusive and Accurate Reproductive Health Research and Quality Improvement. J Midwifery Womens Health. 2025 Jan-Feb; 70(1):131-136.
    View in: PubMed
    Score: 0.087
  8. Hospital Quality Indicators for Opioid-Exposed Infants: Results From an Expert Consensus Panel. Pediatrics. 2024 Jul 01; 154(1).
    View in: PubMed
    Score: 0.086
  9. Performance of Phenotype Algorithms for the Identification of Opioid-Exposed Infants. Hosp Pediatr. 2024 06 01; 14(6):438-447.
    View in: PubMed
    Score: 0.085
  10. County-Level Atrazine Use and Gastroschisis. JAMA Netw Open. 2024 05 01; 7(5):e2410056.
    View in: PubMed
    Score: 0.085
  11. Medications for Opioid Use Disorder During the Prenatal Period and Infant Outcomes. JAMA Pediatr. 2023 11 01; 177(11):1228-1230.
    View in: PubMed
    Score: 0.082
  12. County-level Factors and Treatment Access Among Insured Women With Opioid Use Disorder. Med Care. 2023 12 01; 61(12):816-821.
    View in: PubMed
    Score: 0.079
  13. Laws Forbidding Pregnancy Discrimination in Substance Use Disorder Treatment Are Not Associated With Treatment Access. J Addict Med. 2022 May-Jun 01; 16(3):364-367.
    View in: PubMed
    Score: 0.074
  14. Association of Individual and Community Factors With Hepatitis C Infections Among Pregnant People and Newborns. JAMA Health Forum. 2021 10; 2(10):e213470.
    View in: PubMed
    Score: 0.071
  15. Impact of stigmatizing language describing opioid-exposed mother infant dyads: A randomized case vignette study. Subst Abus. 2022; 43(1):551-555.
    View in: PubMed
    Score: 0.071
  16. Neonatal Abstinence Syndrome and Maternal Opioid-Related Diagnoses: Analysis of ICD-10-CM Transition, 2013-2017. Hosp Pediatr. 2021 08; 11(8):902-908.
    View in: PubMed
    Score: 0.070
  17. Disparities in receipt of medications for opioid use disorder among pregnant women. Subst Abus. 2022; 43(1):508-513.
    View in: PubMed
    Score: 0.070
  18. Reproductive-Age Women's Experience of Accessing Treatment for Opioid Use Disorder: "We Don't Do That Here". Womens Health Issues. 2021 Sep-Oct; 31(5):455-461.
    View in: PubMed
    Score: 0.069
  19. Association of Preterm Birth Rate With COVID-19 Statewide Stay-at-Home Orders in Tennessee. JAMA Pediatr. 2021 Jun 01; 175(6):635-637.
    View in: PubMed
    Score: 0.069
  20. US Hospital Data About Neonatal Abstinence Syndrome and Maternal Opioid-Related Diagnoses-Reply. JAMA. 2021 05 25; 325(20):2120.
    View in: PubMed
    Score: 0.069
  21. Neonatal Abstinence Syndrome and Maternal Opioid-Related Diagnoses in the US, 2010-2017. JAMA. 2021 01 12; 325(2):146-155.
    View in: PubMed
    Score: 0.067
  22. Neonatal Opioid Withdrawal Syndrome. Pediatrics. 2020 11; 146(5).
    View in: PubMed
    Score: 0.066
  23. Development and Validation of a Model to Predict Neonatal Abstinence Syndrome. J Pediatr. 2021 02; 229:154-160.e6.
    View in: PubMed
    Score: 0.066
  24. Association of Pregnancy and Insurance Status With Treatment Access for Opioid Use Disorder. JAMA Netw Open. 2020 08 03; 3(8):e2013456.
    View in: PubMed
    Score: 0.065
  25. Medications for opioid use disorder among pregnant women referred by criminal justice agencies before and after Medicaid expansion: A retrospective study of admissions to treatment centers in the United States. PLoS Med. 2020 05; 17(5):e1003119.
    View in: PubMed
    Score: 0.064
  26. Neonatal Abstinence Syndrome In The United States, 2004-16. Health Aff (Millwood). 2020 05; 39(5):764-767.
    View in: PubMed
    Score: 0.064
  27. Hepatitis C Testing Among Perinatally Exposed Infants. Pediatrics. 2020 03; 145(3).
    View in: PubMed
    Score: 0.063
  28. Opioid Litigation and Maternal-Child Health-Investing in the Future. JAMA Pediatr. 2020 02 01; 174(2):119-120.
    View in: PubMed
    Score: 0.063
  29. Increased Severity of Neonatal Abstinence Syndrome Associated With Concomitant Antenatal Opioid and Benzodiazepine Exposure. Hosp Pediatr. 2019 08; 9(8):569-575.
    View in: PubMed
    Score: 0.061
  30. Neonatal Abstinence Syndrome. Pediatr Clin North Am. 2019 04; 66(2):353-367.
    View in: PubMed
    Score: 0.060
  31. Association Among County-Level Economic Factors, Clinician Supply, Metropolitan or Rural Location, and Neonatal Abstinence Syndrome. JAMA. 2019 01 29; 321(4):385-393.
    View in: PubMed
    Score: 0.059
  32. Positive Predictive Value of Administrative Data for Neonatal Abstinence Syndrome. Pediatrics. 2019 01; 143(1).
    View in: PubMed
    Score: 0.058
  33. Umbilical Cord Tissue and Meconium May Not Be Equivalent for Confirming in Utero Substance Exposure. J Pediatr. 2019 02; 205:277-280.
    View in: PubMed
    Score: 0.058
  34. Barriers to accessing treatment for pregnant women with opioid use disorder in Appalachian states. Subst Abus. 2019; 40(3):356-362.
    View in: PubMed
    Score: 0.058
  35. Prescribing opioids and psychotropic drugs in pregnancy. BMJ. 2017 08 02; 358:j3616.
    View in: PubMed
    Score: 0.053
  36. Treatment of Opioid Use Disorder During Pregnancy and Cases of Neonatal Abstinence Syndrome. JAMA Pediatr. 2017 07 01; 171(7):707.
    View in: PubMed
    Score: 0.053
  37. A Comprehensive Approach to the Opioid Epidemic. Obstet Gynecol. 2017 07; 130(1):7-9.
    View in: PubMed
    Score: 0.053
  38. Nonmedical Use of Prescription Opioids among Pregnant U.S. Women. Womens Health Issues. 2017 May - Jun; 27(3):308-315.
    View in: PubMed
    Score: 0.052
  39. Rural and Urban Differences in Neonatal Abstinence Syndrome and Maternal Opioid Use, 2004 to 2013. JAMA Pediatr. 2017 02 01; 171(2):194-196.
    View in: PubMed
    Score: 0.051
  40. The opioid epidemic and neonatal abstinence syndrome in the USA: a review of the continuum of care. Arch Dis Child Fetal Neonatal Ed. 2017 Mar; 102(2):F183-F187.
    View in: PubMed
    Score: 0.051
  41. Opioid Use Disorder in Pregnancy: Health Policy and Practice in the Midst of an Epidemic. Obstet Gynecol. 2016 Jul; 128(1):4-10.
    View in: PubMed
    Score: 0.049
  42. Promise and peril: Dissemination of findings from studies of drugs used in pregnancy and their association with birth defects. Birth Defects Res A Clin Mol Teratol. 2015 Aug; 103(8):729-32.
    View in: PubMed
    Score: 0.046
  43. Prescription opioid epidemic and infant outcomes. Pediatrics. 2015 May; 135(5):842-50.
    View in: PubMed
    Score: 0.045
  44. Pharmacotherapy research landscape and knowledge gaps of opioids in maternal and pediatric populations. Pharmacotherapy. 2025 06; 45(6):367-385.
    View in: PubMed
    Score: 0.023
  45. Association of Opioid Use Disorder-Related Service Trajectories During Pregnancy and Postpartum Health Service Use: A Group-Based Multitrajectory Modeling Study. J Addict Med. 2025 Jul-Aug 01; 19(4):403-411.
    View in: PubMed
    Score: 0.022
  46. Patient and Community Factors Affecting Treatment Access for Opioid Use Disorder. Obstet Gynecol. 2023 08 01; 142(2):339-349.
    View in: PubMed
    Score: 0.020
  47. Maternal Opioid Use Disorder and the Risk of Postneonatal Infant Mortality. JAMA Pediatr. 2023 07 01; 177(7):675-683.
    View in: PubMed
    Score: 0.020
  48. Treatment access for opioid use disorder among women with medicaid in Florida. Drug Alcohol Depend. 2023 05 01; 246:109854.
    View in: PubMed
    Score: 0.020
  49. Risk of Death at 1 Year Following Postpartum Opioid Exposure. Am J Perinatol. 2024 05; 41(7):949-960.
    View in: PubMed
    Score: 0.019
  50. Assessing Stigma Towards Substance Use in Pregnancy: A Randomized Study Testing the Impact of Stigmatizing Language and Type of Opioid Use on Attitudes Toward Mothers With Opioid Use Disorder. J Addict Med. 2022 Jan-Feb 01; 16(1):77-83.
    View in: PubMed
    Score: 0.018
  51. The risk of serious opioid-related events associated with common opioid prescribing regimens in the postpartum period after cesarean delivery. Am J Obstet Gynecol MFM. 2021 11; 3(6):100475.
    View in: PubMed
    Score: 0.018
  52. Using Public Health Surveillance Data to Determine Hepatitis C Virus Exposure Among Live-Born Infants in Tennessee, 2013-2017. Public Health Rep. 2022 Sep-Oct; 137(5):860-866.
    View in: PubMed
    Score: 0.018
  53. Association between punitive policies and neonatal abstinence syndrome among Medicaid-insured infants in complex policy environments. Addiction. 2022 01; 117(1):162-171.
    View in: PubMed
    Score: 0.017
  54. Prescription Opioid Dose After Vaginal Delivery and the Risk of Serious Opioid-Related Events: A Retrospective Cohort Study. Womens Health Issues. 2021 Jul-Aug; 31(4):376-383.
    View in: PubMed
    Score: 0.017
  55. Antenatal Admissions Among Women with Opioid-Affected and Non-Opioid-Affected Deliveries. Matern Child Health J. 2020 Sep; 24(9):1179-1188.
    View in: PubMed
    Score: 0.016
  56. Well-Child Care Adherence After Intrauterine Opioid Exposure. Pediatrics. 2020 02; 145(2).
    View in: PubMed
    Score: 0.016
  57. Association of Punitive and Reporting State Policies Related to Substance Use in Pregnancy With Rates of Neonatal Abstinence Syndrome. JAMA Netw Open. 2019 11 01; 2(11):e1914078.
    View in: PubMed
    Score: 0.015
  58. Neonatal abstinence syndrome. Nat Rev Dis Primers. 2018 11 22; 4(1):47.
    View in: PubMed
    Score: 0.015
  59. Delivery type, opioid prescribing, and the risk of persistent opioid use after delivery. Am J Obstet Gynecol. 2019 04; 220(4):405-407.
    View in: PubMed
    Score: 0.014
  60. Decision Science Can Help Policymakers to Identify and Evaluate Policies to Treat Opioid Use Disorder Among Pregnant Women. Womens Health Issues. 2018 Jan - Feb; 28(1):2-5.
    View in: PubMed
    Score: 0.014
  61. Pregnancy Intention and Maternal Alcohol Consumption. Obstet Gynecol. 2017 04; 129(4):727-733.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.